Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 287 到 306 筆資料,總共 378 筆
< 上一頁
下一頁 >
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2016
The risk of chronic pancreatitis in patients with psoriasis: A population-based cohort study
HSIEN-YI CHIU
; Hsieh C.-F.; Chiang Y.-T.; Huang W.-F.; TSEN-FANG TSAI
PLoS ONE
9
6
2016
Risk of fractures in vitiligo patients treated with phototherapy-A retrospective population-based cohort study
Lo P.-C.; Li C.-Y.; Huang W.-F.; Tsai Y.-W.; Liu H.-N.; Chang Y.-T.; HSIEN-YI CHIU
; TSEN-FANG TSAI
Journal of Dermatological Science
10
9
2018
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study
HSIEN-YI CHIU
; Chang W.-L.; TSEN-FANG TSAI
; Tsai Y.-W.; Shiu M.-N.
Drug Safety
7
8
2017
Risk of varicocele in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic disease: a population-based case–control study
HSIEN-YI CHIU
; Wang I.-T.; Huang W.-F.; Tsai Y.-W.; TSEN-FANG TSAI
Scandinavian Journal of Rheumatology
1
0
2005
Role of breast tumour kinase in the in vitro differentiation of HaCaT cells
Wang T.C.; Jee S.H.; TSEN-FANG TSAI
; Huang Y.L.; Tsai W.L.; Chen R.-H.
British Journal of Dermatology
29
27
2018
The role of β-blockers in dermatological treatment: a review
Chen L.; TSEN-FANG TSAI
Journal of the European Academy of Dermatology and Venereology
17
17
2013
Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
Wang T.-S.; TSEN-FANG TSAI
Dermatologica Sinica
12
13
2020
Safety and Effectiveness of Hyaluronic Acid Fillers With Lidocaine for Full-Face Treatment in Asian Patients
Huang, She-Hung; TSEN-FANG TSAI
Journal of drugs in dermatology : JDD
3
3
2018
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2
Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI
; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P.
Rheumatology (United Kingdom)
35
33
2020
Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials
Puig L.; TSEN-FANG TSAI
; Bhutani T.; Uy J.; Ramachandran P.; Song M.; You Y.; Gooderham M.; Lebwohl M.
Journal of the European Academy of Dermatology and Venereology
23
17
2012
The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection
TSEN-FANG TSAI
; Ho V.; Song M.; Szapary P.; Kato T.; Wasfi Y.; Li S.; Shen Y.K.; Leonardi C.
British Journal of Dermatology
83
64
2018
Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study
HSIEN-YI CHIU
; Hui R.C.-Y.; Huang Y.-H.; Huang R.-Y.; Chen K.-L.; Tsai Y.-C.; Lai P.-J.; Wang T.-S.; TSEN-FANG TSAI
Acta Dermato-Venereologica
56
45
2013
The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C
HSIEN-YI CHIU
; CHIEN-HUNG CHEN
; Wu M.-S.; Cheng Y.-P.; TSEN-FANG TSAI
British Journal of Dermatology
121
101
2000
Sclerosing Perineurioma
TSEN-FANG TSAI
中華皮膚科醫學雜誌
0
0
2000
Sebaceoma (Sebaceous Epithelioma) -A Case Report-
TSEN-FANG TSAI
中華皮膚科醫學雜誌
0
0
2001
Sebaceous Trichofolliculoma -A Case Report-
TSEN-FANG TSAI
中華皮膚科醫學雜誌
0
0
2001
Sebaceous Trichofolliculoma —A Case Report.
TSEN-FANG TSAI
Dermatol Sinica
2021
Secukinumab 2-weekly vs. 4-weekly dosing in plaque-type psoriasis
TSEN-FANG TSAI
British Journal of Dermatology
1
1
2019
Secukinumab demonstrates superior efficacy and a faster response in clearing skin in Asian subjects with moderate to severe plaque psoriasis compared with ustekinumab: Subgroup analysis from the CLEAR study
Lee M.-G.; Huang Y.-H.; Lee J.-H.; Lee S.-C.; Kim T.-G.; Aw D.C.-W.; Bao W.; Dee C.M.A.; Guana A.; TSEN-FANG TSAI
Journal of Dermatology
10
11
2019
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study
Tha?i D.; Puig L.; Reich K.; TSEN-FANG TSAI
; Tyring S.; Kingo K.; Ziv M.; Pinter A.; Vender R.; Lacombe A.; Xia S.; Bhosekar V.; Gilloteau I.; Guana A.; Blauvelt A.
Journal of the American Academy of Dermatology
15
13